Busulfan (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the Busulfan drug offered from Sagent Pharmaceuticals. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
NON-PROPRIETARY NAME: | Busulfan |
SUBSTANCE NAME: | BUSULFAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-05-15 |
END MARKETING DATE: | 0000-00-00 |
Busulfan HUMAN PRESCRIPTION DRUG Details:
Item Description | Busulfan from Sagent Pharmaceuticals |
LABELER NAME: | Sagent Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6(mg/mL) |
START MARKETING DATE: | 2017-05-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 25021-241_fb195d4c-7f7e-442a-b9b6-a51cc7796e00 |
PRODUCT NDC: | 25021-241 |
APPLICATION NUMBER: | ANDA207050 |
Other BUSULFAN Pharmaceutical Manufacturers / Labelers: